Hunan Jingfeng Pharmaceutical Co.,Ltd. (SHE:000908)
China
· Delayed Price · Currency is CNY 6.37
-0.01 (-0.16%)
Mar 9, 2026, 3:05 PM CST
SHE:000908 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 5,604 | 4,302 | 2,850 | 2,798 | 3,836 | 3,994 | Upgrade
|
| Market Cap Growth | 48.48% | 50.93% | 1.89% | -27.06% | -3.96% | 19.79% | Upgrade
|
| Enterprise Value | 5,782 | 4,767 | 3,316 | 3,367 | 5,039 | 5,203 | Upgrade
|
| Last Close Price | 6.37 | 4.89 | 3.24 | 3.18 | 4.36 | 4.54 | Upgrade
|
| PE Ratio | 35.78 | 28.25 | - | - | - | - | Upgrade
|
| PS Ratio | 14.25 | 10.34 | 4.34 | 3.33 | 4.73 | 4.55 | Upgrade
|
| PB Ratio | -148.43 | -284.36 | -16.32 | 13.88 | 11.70 | 6.26 | Upgrade
|
| P/TBV Ratio | - | 152.38 | - | 92.95 | 22.19 | 11.30 | Upgrade
|
| P/FCF Ratio | 18431.17 | - | 115.67 | 25.49 | 44.75 | - | Upgrade
|
| P/OCF Ratio | 3144.33 | - | 81.29 | 22.70 | 30.98 | - | Upgrade
|
| EV/Sales Ratio | 14.70 | 11.46 | 5.05 | 4.01 | 6.21 | 5.93 | Upgrade
|
| EV/EBITDA Ratio | - | 230.72 | - | 104.46 | - | - | Upgrade
|
| EV/FCF Ratio | 19015.18 | - | 134.56 | 30.68 | 58.79 | - | Upgrade
|
| Debt / Equity Ratio | -7.38 | -31.11 | -3.40 | 2.97 | 2.67 | 2.08 | Upgrade
|
| Debt / EBITDA Ratio | 556.54 | 20.42 | - | 16.65 | - | - | Upgrade
|
| Debt / FCF Ratio | 916.83 | - | 24.10 | 5.46 | 10.19 | - | Upgrade
|
| Net Debt / Equity Ratio | -6.69 | -25.46 | -3.32 | 2.07 | 2.14 | 1.82 | Upgrade
|
| Net Debt / EBITDA Ratio | -133.48 | 18.64 | -8.88 | 12.95 | -3.30 | -1.88 | Upgrade
|
| Net Debt / FCF Ratio | 830.85 | -55.57 | 23.56 | 3.80 | 8.18 | -3.16 | Upgrade
|
| Asset Turnover | 0.41 | 0.42 | 0.52 | 0.52 | 0.36 | 0.25 | Upgrade
|
| Inventory Turnover | 2.54 | 2.85 | 2.14 | 1.49 | 1.67 | 1.18 | Upgrade
|
| Quick Ratio | 0.30 | 0.19 | 0.13 | 0.37 | 0.35 | 0.38 | Upgrade
|
| Current Ratio | 0.39 | 0.25 | 0.21 | 0.53 | 0.50 | 0.55 | Upgrade
|
| Return on Equity (ROE) | - | - | -1685.13% | -35.99% | -41.75% | -89.70% | Upgrade
|
| Return on Assets (ROA) | -1.19% | -0.33% | -5.18% | -0.75% | -8.64% | -12.41% | Upgrade
|
| Return on Invested Capital (ROIC) | -5.92% | -1.33% | -20.36% | -2.36% | -21.89% | -29.36% | Upgrade
|
| Return on Capital Employed (ROCE) | -20.10% | -15.10% | -555.10% | -5.20% | -71.80% | -84.10% | Upgrade
|
| Earnings Yield | 2.79% | 3.54% | -8.28% | -4.38% | -4.27% | -26.75% | Upgrade
|
| FCF Yield | 0.01% | -0.16% | 0.86% | 3.92% | 2.23% | -9.21% | Upgrade
|
| Payout Ratio | 8.58% | 8.80% | - | - | - | - | Upgrade
|
| Buyback Yield / Dilution | -0.01% | -0.02% | 0.02% | 0.01% | 0.36% | -0.03% | Upgrade
|
| Total Shareholder Return | -0.01% | -0.02% | 0.02% | 0.01% | 0.36% | -0.03% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.